disopyramide has been researched along with Hypotension, Postural in 5 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Susceptibility to transient hypotension-bradycardia of neurally mediated origin has been attributed in part to accentuated afferent neural traffic arising from cardiopulmonary mechanoreceptors, and consequently, may be diminished by agents with anticholinergic and negative inotropic effects, such as disopyramide phosphate." | 7.68 | Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. ( Benditt, DG; Buetikofer, J; Dunnigan, A; Gornick, C; Milstein, S; Reyes, WJ, 1990) |
| "Susceptibility to transient hypotension-bradycardia of neurally mediated origin has been attributed in part to accentuated afferent neural traffic arising from cardiopulmonary mechanoreceptors, and consequently, may be diminished by agents with anticholinergic and negative inotropic effects, such as disopyramide phosphate." | 3.68 | Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. ( Benditt, DG; Buetikofer, J; Dunnigan, A; Gornick, C; Milstein, S; Reyes, WJ, 1990) |
| "We conclude that chronic fatigue syndrome is associated with neurally mediated hypotension and that its symptoms may be improved in a subset of patients by therapy directed at this abnormal cardiovascular reflex." | 1.29 | The relationship between neurally mediated hypotension and the chronic fatigue syndrome. ( Bou-Holaigah, I; Calkins, H; Kan, J; Rowe, PC, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bou-Holaigah, I | 1 |
| Rowe, PC | 1 |
| Kan, J | 1 |
| Calkins, H | 2 |
| Seifert, M | 1 |
| Morady, F | 1 |
| Sneddon, JF | 1 |
| Scalia, G | 1 |
| Ward, DE | 1 |
| McKenna, WJ | 1 |
| Camm, AJ | 1 |
| Frenneaux, MP | 1 |
| Milstein, S | 1 |
| Buetikofer, J | 1 |
| Dunnigan, A | 1 |
| Benditt, DG | 1 |
| Gornick, C | 1 |
| Reyes, WJ | 1 |
| Tantengco, MV | 1 |
| Onrot, J | 1 |
| Robertson, D | 1 |
| Robertson, RM | 1 |
| Light, RT | 1 |
5 other studies available for disopyramide and Hypotension, Postural
| Article | Year |
|---|---|
The relationship between neurally mediated hypotension and the chronic fatigue syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Di | 1995 |
Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope.
Topics: Adolescent; Adult; Age of Onset; Atenolol; Bradycardia; Disopyramide; Drug Combinations; Exercise; E | 1995 |
Exercise induced vasodepressor syncope.
Topics: Adolescent; Adult; Aged; Cardiac Output; Disopyramide; Exercise; Exercise Test; Female; Heart Rate; | 1994 |
Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia.
Topics: Adult; Bradycardia; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; Hemodynam | 1990 |
Orthostatic hypotension: clinical spectrum and approach to treatment.
Topics: Adult; Aged; Amiodarone; Disopyramide; Female; Flecainide; Humans; Hypotension, Orthostatic; Lidocai | 1986 |